![Mark Sullivan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark Sullivan
Oprichter bij Medicines Development for Global Health Ltd
Actieve functies van Mark Sullivan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Medicines Development for Global Health Ltd
![]() Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | 01-10-2005 | - | |
Oprichter | 01-10-2005 | - | |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Private Equity Investor | 01-07-2020 | - |
Global Health Funds LLC | Consultant / Adviseur | 01-12-2020 | - |
Loopbaan van Mark Sullivan
Eerdere bekende functies van Mark Sullivan
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
OPTHEA LIMITED | Corporate Officer/Principal | 18-02-2011 | 15-12-2012 |
University of New South Wales Built Environment | Operationeel Directeur | 01-03-2003 | 30-09-2005 |
GILEAD SCIENCES, INC. | Directeur/Bestuurslid | 01-01-2001 | 31-12-2003 |
i3 Global
![]() i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Directeur/Bestuurslid | 01-11-1999 | 31-12-2000 |
Opleiding van Mark Sullivan
Deakin University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 5 |
Australië | 5 |
Operationeel
Director/Board Member | 3 |
Corporate Officer/Principal | 1 |
Chief Executive Officer | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
OPTHEA LIMITED | Health Technology |
Bedrijven in privébezit | 4 |
---|---|
i3 Global
![]() i3 Global Miscellaneous Commercial ServicesCommercial Services i3 Global operates as a pharmaceutical services company. It offers therapeutically specialized contract research solutions, clinical data services, staffing solutions, pharmacovigilance and epidemiology solutions. The company was founded in 1988 and is headquartered in Bernards, NJ. | Commercial Services |
Medicines Development for Global Health Ltd
![]() Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia. | Health Technology |
Adjuvant Capital LP
![]() Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital LP (Adjuvant Capital) is a private equity and venture capital firm founded in 2018 by Glenn Rockman, Kabeer Aziz and Charlie Petty. The firm is headquartered in New York. | Finance |
Global Health Funds LLC |
- Beurs
- Insiders
- Mark Sullivan
- Ervaring